Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 55.41B | 44.74B | 49.34B | 53.95B | 39.11B | 33.15B |
Gross Profit | 24.14B | 23.88B | 23.30B | 20.20B | 17.06B | 16.14B |
EBITDA | 20.18B | 17.53B | 13.92B | 12.77B | 11.80B | 10.12B |
Net Income | 6.19B | 4.80B | 4.80B | 4.34B | 3.88B | 3.61B |
Balance Sheet | ||||||
Total Assets | 162.19B | 158.29B | 150.03B | 154.67B | 141.75B | 122.52B |
Cash, Cash Equivalents and Short-Term Investments | 3.45B | 4.57B | 3.81B | 4.99B | 4.54B | 3.79B |
Total Debt | 60.08B | 57.73B | 61.65B | 50.42B | 44.27B | 40.51B |
Total Liabilities | 101.49B | 97.24B | 89.74B | 96.55B | 85.63B | 75.30B |
Stockholders Equity | 46.96B | 47.13B | 43.11B | 41.12B | 40.48B | 35.41B |
Cash Flow | ||||||
Free Cash Flow | 1.25B | 2.05B | 4.25B | 3.66B | 1.19B | 2.50B |
Operating Cash Flow | 5.88B | 11.93B | 12.13B | 10.44B | 8.11B | 8.35B |
Investing Cash Flow | -5.92B | -8.40B | -9.69B | -10.15B | -9.49B | -6.64B |
Financing Cash Flow | -5.61B | -2.27B | -4.09B | 151.00M | 1.87B | -71.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $6.48B | 4.93 | 22.94% | 15.74% | -3.27% | -3.44% | |
79 Outperform | $124.41B | 21.35 | 10.61% | 3.86% | -1.57% | -20.88% | |
75 Outperform | $53.36B | 19.78 | 8.87% | 3.08% | 0.46% | -11.77% | |
72 Outperform | $6.40B | 12.56 | 9.81% | 6.19% | -5.28% | 14.50% | |
67 Neutral | $17.66B | 18.13 | 5.33% | 3.62% | 7.33% | 12.21% | |
65 Neutral | $20.33B | 1,586.60 | 1.06% | 5.32% | 8.86% | ― | |
65 Neutral | $9.50B | 9.52 | 21.17% | 5.24% | -3.19% | 30.48% |